Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: November 19, 2025
Filtering and Copper Nanoparticle Intra-Vas Device
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Permanent
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): Family Planning Research Institute, Tongji Medical College
Inactive
Last updated: November 18, 2025
EVO100 Gel

Phexxi + OB-002

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Gel
  • Intended Duration: Pericoital
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): EvoFem
Inactive
Last updated: November 18, 2025
EVE-112 Vaginal Ring

Etonogestrel (ENG) + Ethinyl Estradiol (EE) Vaginal Ring, EVE-112

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): Evestra, Inc., Gedeon Richter Plc.
Inactive
Last updated: November 18, 2025
ENG + E2 Vaginal Ring

Merck Vaginal Ring, MK-8342B

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Undetermined
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): Merck
Inactive
Last updated: November 18, 2025
Duet Diaphragm
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Multiple
  • Intended Duration: Pericoital
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): ReProtect Inc.
Active
Last updated: November 18, 2025
CTP of β-hCG Vaccine

Carboxy Terminus Peptide of β-Human Chorionic Gonadotropin

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Talwar Research Foundation, Indian Council for Medical Research
Active
Last updated: November 18, 2025
Choice Reversible Sterilization Device
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Fallopian Tube
  • Intended Duration: Permanent
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Choice, Máxima Medisch Centrum
Active
Last updated: November 17, 2025
Alternative Metal IUDs

Zinc IUD, Iron IUD

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): The University of Sydney, University of Western Ontario
Active
Last updated: November 13, 2025
Upsilon IUD
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Upsilon Health
Active
Last updated: November 12, 2025
Nestorone-Only Vaginal Ring
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Population Council